抗PM/Scl抗体阳性特发性炎性肌病患者的临床特征
这项回顾性队列研究比较了单纯抗PM/Scl抗体阳性与合并肌炎特异性抗体(MSA)双阳性的特发性炎性肌病患者,发现间质性肺病(ILD)是最突出表现,双阳性组ILD更常见且死亡率更高,而单纯抗PM/Scl抗体组免疫治疗后预后良好。
要点
- 65例抗PM/Scl抗体阳性特发性炎性肌病患者中,34例(52.3%)合并MSA。
- 双阳性组ILD发生率90.6%高于单纯组67.9%(p=0.028),死亡率20.6%高于单纯组0(p=0.034)。
- 单纯抗PM/Scl抗体组女性比例90.3%高于双阳性组67.6%(p=0.026),硬指发生率16.1%高于双阳性组0(p=0.021)。
核心结论
- 抗PM/Scl抗体阳性特发性炎性肌病患者中,ILD是突出临床特征,合并MSA时尤为明显。
- 单纯抗PM/Scl抗体阳性患者免疫治疗后预后良好。
研究设计与样本
- 回顾性队列研究,纳入65例抗PM/Scl抗体阳性的特发性炎性肌病患者,比较单纯抗PM/Scl抗体阳性组与抗PM/Scl抗体合并MSA双阳性组的临床表现。
主要发现
- 65例患者中女性51例(78.5%),平均年龄49.1岁;34例(52.3%)合并MSA。
- 单纯抗PM/Scl抗体组女性比例90.3% vs 双阳性组67.6%(p=0.026),硬指发生率16.1% vs 0(p=0.021)。
- 两组肌无力、吞咽困难及肌酸激酶水平无差异,但大腿MRI显示单纯组肌肉水肿、萎缩和脂肪替代更少(p<0.05)。
- ILD发生率为80%,双阳性组90.6% vs 单纯组67.9%(p=0.028);HRCT显示非特异性间质性肺炎(NSIP)为最常见类型。
- 双阳性组铁蛋白水平更高、外周血淋巴细胞计数更低(p<0.05);双阳性组死亡率20.6% vs 单纯组0(p=0.034)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To analyze the clinical features of idiopathic inflammatory myopathies (IIMs) patients with anti-PM/Scl antibodies. METHODS: In this retrospective cohort study, we compared the clinical manifestations between patients who were solely positive for anti-PM/Scl antibodies (isolated anti-PM/Scl group) and those with a coexistence of anti-PM/Scl antibodies and myositis-specific antibodies (MSAs) (double-positive group). RESULTS: Sixty-five IIMs patients positive for anti-PM/Scl antibodies were included, among whom 51 (78.5 %) were females, with a mean age of 49.1 years. Thirty-four (52.3 %) patients coexisted with MSAs. Compared to the double-positive group, the isolated anti-PM/Scl group demonstrated a higher proportion of women (90.3 % vs 67.6 %, p = 0.026) and a higher incidence of sclerodactyly (16.1 % vs 0, p = 0.021). Although there were no differences in the incidence of muscular weakness, dysphagia, or creatine kinase levels, thigh magnetic resonance imaging (MRI) revealed less muscle edema, atrophy, and fatty replacement in the isolated anti-PM/Scl group (p < 0.05). Interstitial lung disease (ILD) occurred in 80 % of patients, more frequently in the double-positive group (90.6 % vs 67.9 %, p = 0.028). According to HRCT, non-specific interstitial pneumonia (NSIP) was the most common pattern among anti-PM/Scl antibodies positive IIMs patients. The double-positive group exhibited higher ferritin levels, and a lower peripheral lymphocyte count (p < 0.05). The mortality rate in the double-positive group was higher than that in the isolated anti-PM/Scl group (20.6 % vs 0, p = 0.034). CONCLUSION: Among IIMs patients who tested positive for anti-PM/Scl antibodies, ILD emerged as the predominant clinical feature, particularly when combined with MSA. Notably, patients with isolated anti-PM/Scl antibodies exhibited a favorable prognosis following immunotherapy.
引用
- Zhu L, Zong C, Chen Y, et al. Clinical characteristics of idiopathic inflammatory myopathies patients with anti-PM/Scl antibodies. Semin Arthritis Rheum. 2024. PMID: 39178740. doi:10.1016/j.semarthrit.2024.152536
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。